Cincinnati, OH – April 4, 2019 – Standard Bariatrics is developing products to improve the consistency and clinical outcomes of sleeve gastrectomy, the surgical procedure most commonly used in the United States to treat morbid obesity.
Standard Bariatrics received the 2018 Innovation & Technology Award in the category of Outstanding Bioscience from the Business Courier‘s eighth-annual Innovation & Technology Awards, recognizing companies that are fueling growth through innovative processes and products.
Read the full article on Cincinnati Business Courier
Standard Bariatrics, Inc., an innovator of bariatric surgical devices, has raised a Series A round of financing. RiverVest Venture Partners led the round with participation from Hatteras Venture Partners, Queen City Angels/QCA First Fund V, Emergent Medical Partners, Accelerant Fund and North Coast Angels. The size of the round is undisclosed.
“This new capital will enable us to complete our product development plans to launch new products for use in gastric procedures,” said Matt Sokany, CEO of Standard Bariatrics.
Read the full article on EurekaAlert!